<DOC>
	<DOCNO>NCT00795951</DOCNO>
	<brief_summary>An open , prospective , single-site , non-randomized study efficacy safety T.R.U.E . TEST Panel 1.1 , 2.1 3.1 allergen child adolescent</brief_summary>
	<brief_title>Clinical Evaluation T.R.U.E . TEST Children Adolescents</brief_title>
	<detailed_description>An open , prospective , single-site , non-randomized study efficacy safety T.R.U.E . TEST Panel 1.1 , 2.1 3.1 allergen child adolescent . After consent enrollment , timeline follow : A. T.R.U.E . TEST panel 1.1 , 2.1 ,3.1 apply skin subject 's back . All patch test panel remain back remove # 2 Clinic Visit occur 2 day later . B . Skin reaction patch test panel allergen evaluate score shortly panel removal.C . Skin reaction evaluate score either 3 4 day # 1 Clinic Visit . An additional follow-up visit ( # 3B Clinic Visit ) may occur day day 0 need verify skin reactions.D . Skin reaction evaluate scored # 4 Clinic Visit , occur 7 day +/- 2 day # 1 Clinic Visit ( day 0 ) . E. A follow visit take place approximately 3 week ( 21 + 2 day ) # 1 Clinic Visit ( day 0 ) record late persistent reaction , adverse event . Investigators may elect perform evaluation via telephone reaction present .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<criteria>Symptoms history potentially consistent allergic contact dermatitis base symptom clinical history ( i.e. , subject visit clinic/physician diagnose , treat resolve condition ) . Children adolescents 6 18 year age , general good health . Adolescent females 15 year age old ( menarche ) must consent urine pregnancy test ; urine test result must negative study inclusion . Informed consent must sign understood subject . If underage , informed consent must sign understood parent legal guardian , consistent institutional , local national regulation . Topical corticosteroid treatment last 7 day near test area . Systemic treatment corticosteroid immunosuppressive last 7 day . Subjects currently receive ( receive previous 3 week ) investigational drug , treatment device , participate another clinical study . Treatment ultraviolet ( UV ) light ( include tan ) previous 3 week . Acute dermatitis outbreak dermatitis near test area back . Subjects unable comply activity restriction ( e.g. , protect test panel excess moisture due shower vigorous activity ) . Subjects unable unwilling comply multiple return visit . Female subject 15 year age ( onset menarche ) old unable consent urine pregnancy test , positive pregnancy test .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>allergic</keyword>
	<keyword>contact dermatitis</keyword>
	<keyword>contact allergy</keyword>
	<keyword>Type IV</keyword>
	<keyword>Children</keyword>
	<keyword>TRUE TEST</keyword>
</DOC>